Gregory L. Cowan - 18 Jun 2021 Form 4 Insider Report for Osmotica Pharmaceuticals plc

Role
Director
Signature
/s/ Christopher Klein, as attorney-in-fact
Issuer symbol
N/A
Transactions as of
18 Jun 2021
Net transactions value
-$53,708
Form type
4
Filing time
22 Jun 2021, 16:05:42 UTC
Next filing
03 Sep 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVLP Ordinary Shares Tax liability $53,708 -18,584 -25% $2.89* 55,561 18 Jun 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.